US FDA Should Explain How It Uses Patient Experience Data In Drug Approvals – Report

 
• By Sue Sutter
  
Trajectory
Product sponsors and other stakeholders say FDA is on a good trajectory when it comes to using patient experience data. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet